Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-20

FDA Approved: DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approves a generic diphenoxylate hydrochloride and atropine sulfate product under an Original Application from Leading Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenoxylate hydrochloride and atropine sulfate (Diphenoxylate hydrochloride and atropine sulfate)

Snippet

ORIG AP for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE)